Pmv Net Working Capital vs Other Current Liab Analysis
PMVP Stock | USD 2.15 0.01 0.46% |
Pmv PharmaceuticalsI financial indicator trend analysis is much more than just breaking down Pmv PharmaceuticalsInc prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Pmv PharmaceuticalsInc is a good investment. Please check the relationship between Pmv PharmaceuticalsI Net Working Capital and its Other Current Liab accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pmv PharmaceuticalsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
Net Working Capital vs Other Current Liab
Net Working Capital vs Other Current Liab Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Pmv PharmaceuticalsInc Net Working Capital account and Other Current Liab. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Pmv PharmaceuticalsI's Net Working Capital and Other Current Liab is 0.81. Overlapping area represents the amount of variation of Net Working Capital that can explain the historical movement of Other Current Liab in the same time period over historical financial statements of Pmv PharmaceuticalsInc, assuming nothing else is changed. The correlation between historical values of Pmv PharmaceuticalsI's Net Working Capital and Other Current Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Working Capital of Pmv PharmaceuticalsInc are associated (or correlated) with its Other Current Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Current Liab has no effect on the direction of Net Working Capital i.e., Pmv PharmaceuticalsI's Net Working Capital and Other Current Liab go up and down completely randomly.
Correlation Coefficient | 0.81 |
Relationship Direction | Positive |
Relationship Strength | Strong |
Net Working Capital
Other Current Liab
Most indicators from Pmv PharmaceuticalsI's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Pmv PharmaceuticalsInc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pmv PharmaceuticalsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. At this time, Pmv PharmaceuticalsI's Tax Provision is relatively stable compared to the past year. As of 05/17/2024, Issuance Of Capital Stock is likely to grow to about 52.1 M, while Selling General Administrative is likely to drop slightly above 17.1 M.
2021 | 2022 | 2023 | 2024 (projected) | Interest Income | 449K | 3.6M | 9.8M | 10.3M | Net Interest Income | 449K | 3.6M | 9.8M | 10.3M |
Pmv PharmaceuticalsI fundamental ratios Correlations
Click cells to compare fundamentals
Pmv PharmaceuticalsI Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Pmv PharmaceuticalsI fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 103.0M | 365.5M | 331.6M | 270.3M | 252.2M | 254.1M | |
Other Current Liab | 1.7M | 4.8M | 8.6M | 7.3M | 9.9M | 6.2M | |
Total Current Liabilities | 4.5M | 6.4M | 12.2M | 10.8M | 14.0M | 9.2M | |
Total Stockholder Equity | (70.5M) | 359.1M | 308.6M | 246.0M | 225.7M | 187.5M | |
Net Tangible Assets | (70.5M) | 359.1M | 308.6M | 246.0M | 282.9M | 175.4M | |
Property Plant And Equipment Net | 739K | 569K | 13.2M | 20.5M | 19.0M | 10.1M | |
Net Debt | 95.7M | (361.4M) | (161.3M) | (94.3M) | (25.2M) | (26.5M) | |
Retained Earnings | (75.4M) | (109.9M) | (167.7M) | (241.0M) | (310.0M) | (294.5M) | |
Accounts Payable | 2.8M | 1.6M | 3.2M | 3.0M | 3.2M | 2.7M | |
Cash | 73.3M | 361.4M | 172.5M | 108.3M | 38.5M | 36.6M | |
Non Current Assets Total | 940K | 770K | 30.3M | 23.3M | 44.7M | 47.0M | |
Cash And Short Term Investments | 101.5M | 361.4M | 297.2M | 241.1M | 203.9M | 232.3M | |
Common Stock Shares Outstanding | 43.0M | 44.8M | 45.1M | 45.6M | 48.0M | 47.3M | |
Short Term Investments | 28.2M | 0.0 | 124.7M | 132.8M | 165.4M | 88.5M | |
Liabilities And Stockholders Equity | 103.0M | 365.5M | 331.6M | 270.3M | 252.2M | 254.1M | |
Non Current Liabilities Total | 169.0M | 1.6M | 10.8M | 13.4M | 12.4M | 11.8M | |
Other Current Assets | 607K | 3.3M | 3.3M | 5.1M | 3.5M | 3.0M | |
Other Stockholder Equity | 4.8M | 103.5M | 476.4M | 487.5M | 535.5M | 295.5M | |
Total Liab | 173.5M | 6.4M | 23.0M | 24.3M | 26.5M | 48.4M | |
Net Invested Capital | (70.5M) | 359.1M | 308.6M | 246.0M | 225.7M | 187.5M | |
Property Plant And Equipment Gross | 739K | 569K | 13.2M | 20.5M | 22.3M | 23.4M | |
Total Current Assets | 102.1M | 364.8M | 301.3M | 247.0M | 207.4M | 235.5M | |
Net Working Capital | 97.6M | 358.4M | 289.1M | 236.2M | 193.4M | 226.3M | |
Property Plant Equipment | 739K | 569K | 13.2M | 11.0M | 12.6M | 13.2M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pmv PharmaceuticalsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Pmv Stock analysis
When running Pmv PharmaceuticalsI's price analysis, check to measure Pmv PharmaceuticalsI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pmv PharmaceuticalsI is operating at the current time. Most of Pmv PharmaceuticalsI's value examination focuses on studying past and present price action to predict the probability of Pmv PharmaceuticalsI's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pmv PharmaceuticalsI's price. Additionally, you may evaluate how the addition of Pmv PharmaceuticalsI to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |
Is Pmv PharmaceuticalsI's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pmv PharmaceuticalsI. If investors know Pmv will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pmv PharmaceuticalsI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.32) | Return On Assets (0.19) | Return On Equity (0.29) |
The market value of Pmv PharmaceuticalsInc is measured differently than its book value, which is the value of Pmv that is recorded on the company's balance sheet. Investors also form their own opinion of Pmv PharmaceuticalsI's value that differs from its market value or its book value, called intrinsic value, which is Pmv PharmaceuticalsI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pmv PharmaceuticalsI's market value can be influenced by many factors that don't directly affect Pmv PharmaceuticalsI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pmv PharmaceuticalsI's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pmv PharmaceuticalsI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pmv PharmaceuticalsI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.